Immuneering

About:

Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.

Website: http://immuneering.com

Twitter/X: immuneering

Top Investors: Cormorant Asset Management, Surveyor Capital, Rock Springs Capital, Ion Pacific, Boxcar Capital Partners

Description:

Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. It has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses.